Health Care & Life Sciences » Pharmaceuticals | Celltrion Pharm Inc.

Celltrion Pharm Inc. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
11,619
3,564
10,417
10,510
5,953
Total Accounts Receivable
40,579
59,047
61,097
91,665
135,654
Inventories
82,315
75,926
73,742
78,872
65,243
Other Current Assets
6,381
7,887
4,094
3,796
4,257
Total Current Assets
140,895
146,424
149,350
184,843
211,107
Net Property, Plant & Equipment
145,624
196,120
219,162
209,836
199,864
Total Investments and Advances
2,681
1,609
2,215
1,333
1,333
Long-Term Note Receivable
3,000
4,754
1,164
900
314
Intangible Assets
46,245
56,723
82,734
95,450
89,257
Other Assets
19,460
-
833
1,671
1,426
Total Assets
361,354
411,165
466,772
510,022
519,619
ST Debt & Current Portion LT Debt
19,366
84,253
101,823
49,732
96,124
Accounts Payable
936
864
2,238
12,765
13,169
Income Tax Payable
467
559
2
1,214
1
Other Current Liabilities
5,852
25,884
8,427
8,675
14,997
Total Current Liabilities
26,622
111,560
112,490
72,387
124,290
Long-Term Debt
165,570
85,148
114,963
89,000
48,125
Provision for Risks & Charges
749
778
959
987
1,230
Deferred Taxes
3,449
5,534
11,314
15,989
16,319
Total Liabilities
192,941
197,486
228,411
162,375
173,646
Common Equity (Total)
168,412
213,678
235,360
344,648
342,974
Total Shareholders' Equity
168,412
213,678
235,360
344,648
342,974
Total Equity
168,412
213,678
235,360
344,648
342,974
Liabilities & Shareholders' Equity
361,354
411,165
466,772
510,022
519,619
Non-Equity Reserves
-
-
3,000
3,000
3,000

About Celltrion Pharm

View Profile
Address
82 2sandan-ro
Cheongju-si NC 28117
Korea, Republic Of
Employees -
Website http://www.celltrionph.com
Updated 09/14/2018
Celltrion Pharm, Inc. engages in the manufacture and sale of pharmaceuticals. Its products are categorized into the following: the group of medicine effect, biosimilars and over-the-counter (OTC) drug. The group of medicine effect includes hepatotonics, hepatotonics and anti-inflammatory drugs, antihistamine, respiratory apparatus drugs, circulatory system drug, digestives and stomachics drug, hormone and metabolic disease drugs, antibiotics and antimycotic, nutrientia and tonic, immunology, oncology, and the other drugs.